Endo International has revealed that its Par Sterile Products division is now shipping posaconazole injection (18 mg/mL) in the United States. This marks the first generic version of Merck’s Noxafil, following the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application. Posaconazole injection is prescribed for the prevention […]
Dr. Reddy’s Laboratories said that it has launched Posaconazole Delayed-Release Tablets, 100 mg, a triazole antifungal drug, in the US market. Posaconazole Delayed-Release Tablets is the therapeutic generic equivalent to NOXAFIL (posaconazole) Delayed-Release Tablets, 100 mg, which has approval from the US Food and Drug Administration. According to IQVIA, the NOXAFIL brand and generic had […]
